Belinda Cochrane

机构：Camden and Campbelltown Hospitals, Western Sydney University · ORCID：0000-0001-8335-0353

发表论文 60 篇 · 总被引 1065 次 · h-index 13

代表论文

• Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with Biologics (2025 · American Journal of Respiratory and Critical Care Medicine · 被引 17)
• A Randomized Trial of Nafamostat for Covid-19 (2023 · NEJM Evidence · 被引 15)
• Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World Data (2025 · The Journal of Allergy and Clinical Immunology In Practice · 被引 14)
• Bisoprolol to prevent adverse cardiac events (PACE) in COPD: a multicentre, double-blind, randomised, controlled, phase 3 trial (2026 · The Lancet Respiratory Medicine · 被引 6)
• Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR) (2025 · World Allergy Organization Journal · 被引 4)
• Acute effects of low-dose bisoprolol on lung function and blood pressure in COPD patients (2025 · ERJ Open Research · 被引 1)